Highlights

In brief

Advanced proteomics and peptidomics show Rhizopus fermentation enriches tempeh’s proteins by pre-digesting them, producing insulin-like peptides and reducing allergens, with implications for enhanced nutrition and gut health.

Photo by Jepretualang | Unsplash

Good things happen when microbes meet soy

18 Aug 2025

Scientists dig into tempeh to uncover how microbial action breaks down soybean proteins into smaller, more digestible and more nutritious forms.

Fermented foods such as yoghurt, kimchi and kombucha are often celebrated for their digestive and health benefits. But what is it about fermentation that gives these foods their supposedly healthy edge? How do their nutrients differ before and after?

In a recent study, a team of researchers from the A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) and A*STAR Institute of Food and Biotechnology Innovation (A*STAR SIFBI) took a dive into tempeh fermentation to examine its molecular-level effects on the humble soybean.

“Tempeh is more than just soybeans inoculated with Rhizopus fungi. Its microbial complexity, culinary potential and nutritional depth are more sophisticated than people realise,” said Jayantha Gunaratne, a Senior Principal Scientist and Head of the Translational Biomedical Proteomics lab at A*STAR IMCB. “The right fermentation and preparation techniques can not only improve tempeh’s flavour and texture, but also enhance its protein profile in ways we’re only starting to understand.”

Gunaratne and colleagues—including Jia Yee Wu, formerly of A*STAR SIFBI and now a Scientist at A*STAR IMCB, and A*STAR Senior Adviser Christiani Jeyakumar Henry—used advanced proteomics and peptidomics tools to study how soybean proteins are broken down by Rhizopus and other microbes during tempeh production. They analysed the mix of peptides—chains of amino acids—released as such proteins are digested by microbial enzymes. The peptides were then compared to those in commercial soybeans.

A major hurdle for the team was the absence of a complete protease database for Rhizopus with which to identify enzymes responsible for protein degradation. Instead, they used a nonspecific enzyme search strategy to infer the types of proteases involved, applying advanced spectral processing and peptide analysis to analyse protein cleavage sites and detect patterns in protein breakdown.

“This approach revealed peptides typically overlooked by conventional analysis, shedding light on the diverse proteolytic activities of the microbes involved,” said Gunaratne.

The team identified over 48,000 peptides derived from soybean proteins after microbial digestion. They also mapped the combined roles of several fungal and bacterial enzymes in enriching tempeh’s nutritional and functional profiles.

Gunaratne highlighted the role of mass spectrometry-based proteomics in their study’s novel findings. These included the reduction of allergenic proteins in tempeh compared to soy, which highlights its potential as a hypoallergenic plant-based protein; as well as the release of insulin-like peptides during microbial digestion that may enhance insulin sensitivity and support metabolic health.

“Proteomics allows us to pick up subtle changes in food composition that conventional methods often miss, making it a powerful tool not just for nutrition research, but also for improving food safety and quality control,” said Gunaratne.

Next, the team aims to investigate the fate of microbially-digested tempeh peptides in the human gut, particularly their interactions with gut cells and microbiota, as well as their potential influence on immunity or gut health.

The A*STAR-affiliated researchers contributing to this research are from the A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) and A*STAR Institute of Food and Biotechnology Innovation (A*STAR SIFBI).

Want to stay up to date with breakthroughs from A*STAR? Follow us on Twitter and LinkedIn!

References

Wu, J.Y., Wee, S., Ler, S.G., Henry, C.J. and Gunaratne, J. Unraveling the impact of tempeh fermentation on protein nutrients: An in vitro proteomics and peptidomics approach.  Food Chemistry474, 143154 (2025). | article

About the Researchers

View articles

Jayantha Gunaratne

Senior Principal Scientist and Deputy Director, Cell & Molecular Therapy Division

A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB)
Jayantha Gunaratne is a Senior Principal Scientist with over two decades of extensive experience in biochemical and biomedical research. He has been the head of the Translational Biomedical Proteomics lab at the A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) since 2011. He obtained his Doctor of Science degree from the Tokyo Institute of Technology, Japan, and postdoctoral training from Script Institution, the University of California San Diego in La Jolla, California. In 2007, he joined A*STAR IMCB as a founding member of the newly formed Advanced Mass Spectrometry and Systems Biology lab, pioneering the establishment of state-of-the-art proteomics technology in Singapore. Gunaratne’s academic experiences include serving as an adjunct faculty in medical schools including Yong Loo Lin School of Medicine, NUS, and Lee Kong Chian School of Medicine, NTU, Singapore. He is currently the Deputy Director of the Cell and Molecular Therapy division in A*STAR IMCB. His group’s current research focuses on the discovery and development of ectoproteomic-centric disease functional biomarkers including therapeutic targets.
Jia Yee Wu is a Scientist at the Translational Biomedical Proteomics Lab (Jayantha Gunaratne's Lab) at A*STAR IMCB. She is passionate about advancing research at the intersection of bioactive and translational medicine to promote health. Leveraging cutting-edge, mass-spectrometry-based proteomics, she maps proteomic signatures, dissects molecular pathways, and profiles proteolytic-cleavage patterns to reveal how specific bioactive molecules modulate human physiology, with the goal of turning these insights into tangible health interventions. Wu earned her PhD degree at the Institute of Translational Medicine, ETH Zürich, Switzerland, where she uncovered novel protein-homeostasis regulators that shape ageing and lifespan. Driven by curiosity and a commitment to impact, she now harnesses state-of-the-art proteomics to illuminate and promote human health span.

This article was made for A*STAR Research by Wildtype Media Group